Date: 29/07/2022

To,

National Stock Exchange of India Ltd.

BSE Limited

Exchange Plaza, Bandra Kurla Complex,

Phiroze Jeejeebhoy Towers,

Bandra (East), Mumbai- 400 051

Dalal Street, Mumbai- 400 001

Symbol: MOREPENLAB

Scrip Code: 500288

Ref: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")

Subject: Outcome of the meeting of the Board of Directors of Morepen Laboratories Limited ("company")

Dear Sir/ Ma'am,

Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform that the Board of Directors of the company in their meeting held today i.e., Friday, 29th July, 2022 (commenced at 11:15 A.M. and concluded at 1.30 P.M.), have, inter-alia, considered and approved: -

  1. Un-auditedstandalone and consolidated financial results of the company for the quarter ended 30th June, 2022.
    Pursuant to Regulation 33 of the SEBI Listing Regulations, a copy of the 'Results' along- with Limited Review Report of the Statutory Auditors of the company, are enclosed herewith.
  2. Re-appointmentof Mr. Sanjay Suri (DIN:00041590) as Whole-Time Director of the company for a further period of 3 years with effect from 13th August, 2022, subject to the approval of shareholders in the ensuing Annual General Meeting of the company.
    The relevant information pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, is enclosed herewith as Annexure A.
  3. Appointment of M/s. S.P. Babuta & Associates, Chartered Accountants (FRN: 007657N), as Statutory Auditors of the company on account of completion of term of five consecutive years of the existing Statutory Auditors, i.e., M/s. Satinder Goyal & Co., Chartered Accountants (FRN:027334N), at the conclusion of the ensuing 37th Annual General Meeting of the company.

Morepen Laboratories Limited

CIN No: L24231 HP1984PLC006028

Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector 20, Gurugram, Haryana-122016, INDIA

Tel.: +91 124 4892000, E-mail: corporate@morepen.com, Website: www.morepen.com

Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA

Tel.: +91-1795-266401-03, 244590, Fax: +91-1795-244591,E-mail: plants@morepen.com

M/s S.P. Babuta & Associates, Chartered Accountants has been appointed for a term of five consecutive years i.e., from the conclusion of the 37th Annual General Meeting until the conclusion of the 42nd Annual General Meeting, subject to the approval of shareholders in the ensuing Annual General Meeting.

The relevant information pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, is enclosed herewith as Annexure B.

  1. Alteration of 'Capital Clause' of Memorandum of Association of the company by re- classification of authorised preference share capital from 1,20,00,000 preference shares of Rs. 100/- each to 50,00,000 preference shares of Rs. 100/- each and authorised equity share capital from 65,00,00,000 equity shares of Rs. 2/- each to 100,00,00,000 equity shares of Rs. 2/- each, subject to approval of the shareholders in the ensuing Annual General Meeting.
  2. Alternation of clause 10 (1) (c) of the Articles of Association of the company by omitting the line 'if the price of such shares is determined by the valuation report of a registered valuer' from the said clause, subject to approval of the shareholders in the ensuing Annual General Meeting.

You are requested to take note of the same in your records.

Thanking you,

Yours faithfully,

For Morepen Laboratories Limited

Vipul Kumar Srivastava

Company Secretary

Encl.: As above

Morepen Laboratories Limited

CIN No: L24231 HP1984PLC006028

Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector 20, Gurugram, Haryana-122016, INDIA

Tel.: +91 124 4892000, E-mail: corporate@morepen.com, Website: www.morepen.com

Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA

Tel.: +91-1795-266401-03, 244590, Fax: +91-1795-244591,E-mail: plants@morepen.com

Annexure-A

Details as per SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD/4/2015 dated September 09, 2015;

S.

Particulars

Details

no.

1.

Reason

for

change

viz.

Re-appointment on completion of tenure of 3

appointment,

resignation,

years.

removal, death or otherwise

2. Date of appointment/cessation (asMr. Sanjay Suri is re-appointed as Whole-Time

applicable)

&

term

of

Director for a further period of 3 years with effect

appointment

from 13th August, 2022, subject to the approval of

shareholders in the ensuing Annual General

Meeting of the company.

3.

Brief profile

Mr. Sanjay Suri is a Bachelor of Science (B.Sc.),

having more than 29 years of experience in

pharmaceuticals industry. He has varied

experience in the field of accounts, finance,

banking and international sales and marketing,

exports, joint ventures, statutory and regulatory

approvals related to USFDA, strategic planning

and manufacturing etc.

4.

Disclosure

of

relationships

Mr. Sanjay Suri is a member of promoter group

between directors

of the company and brother of Mr. Sushil Suri,

Chairman and Managing Director of the

company.

Morepen Laboratories Limited

CIN No: L24231 HP1984PLC006028

Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector 20, Gurugram, Haryana-122016, INDIA

Tel.: +91 124 4892000, E-mail: corporate@morepen.com, Website: www.morepen.com

Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA

Tel.: +91-1795-266401-03, 244590, Fax: +91-1795-244591,E-mail: plants@morepen.com

Annexure-B

Details as per SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD/4/2015 dated September 09, 2015;

S.

Particulars

Details

no.

1. Reason for change viz. appointment, resignation, removal, death or otherwise

Appointment of M/s. S.P. Babuta & Associates, Chartered Accountants, as Statutory Auditors of the company on account of completion of term of five consecutive years of the existing Statutory Auditors, i.e., M/s. Satinder Goyal & Co., Chartered Accountants, at the ensuing 37th Annual General Meeting of the company.

2. Date of appointment/cessation (as applicable)& term of appointment

Subject to the approval of shareholders in the ensuing Annual General Meeting, M/s. S.P. Babuta & Associates, Chartered Accountants will be appointed for a term of five consecutive years i.e., from the conclusion of the 37th Annual General Meeting until the conclusion of the 42nd Annual General Meeting.

3.

Brief profile

M/s. S.P. Babuta & Associates, Chartered

Accountants 'A Peer Reviewed Firm' was

established in the year 1987 by CA. S. P. Babuta,

Chartered Accountant. Mr. S. P. Babuta,

Managing Partner having experience of over 35

years in the field of taxation, audit, project

finance, forensic audit, insolvency resolution

professional services and specialized in rendering

financial advice to various reputed corporates and

multinational companies. The head office of the

firm is located at Chandigarh and branches at

New Delhi and Mohali.

4.

Disclosure of relationships

Not applicable

between directors

Morepen Laboratories Limited

CIN No: L24231 HP1984PLC006028

Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector 20, Gurugram, Haryana-122016, INDIA

Tel.: +91 124 4892000, E-mail: corporate@morepen.com, Website: www.morepen.com

Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA

Tel.: +91-1795-266401-03, 244590, Fax: +91-1795-244591,E-mail: plants@morepen.com

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Morepen Laboratories Ltd. published this content on 29 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 July 2022 10:47:05 UTC.